Ronald Mann, Justices poised to protect generics manufacturers from liability for decisions of pharmacists about prescribing ...
The justices are set to hear Hikma v. Amarin, a battle over drug patents that could raise costs for patients and change the ...
The Food and Drug Administration said late Tuesday it would not approve any generic versions of OxyContin based on the original formulation because it "poses an increased potential for certain types ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results